Fundraising FoxSwift Biosciences
Ann Arbor, US · Founded 2009 · Delaware corporation · 1 known investors
Find your way into Swift Biosciences
Sign up to see every warm intro you have to Swift Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Swift Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Exit: Acquired by Integrated DNA Technologies, March 2021.
Founders & leadership
TH
Tim HarkinsExecutiveTim Harkins has more than 20 years of experience in research, product development, and commercialization in genomics and life sciences, with work spanning next-generation sequencing platforms, real-time PCR, microarray, and bioinformatics software. He holds an executive officer and director role at Swift Biosciences.
DO
David OlsonExecutive
VM
Vladimir MakarovNamed on SEC filing
Board
PK
Peter KleinhenzBoard director
DW
Dan WatkinsBoard director
WY
Walter YoungBoard director
JB
Jack Ball, Jr.Board director
Investors · 1
Arboretum Ventureslisted by Arboretum VenturesAnn Arbor · $5M – $15M
How we know: Arboretum Ventures's portfolio page · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$24.5M disclosed across 6 rounds · 2012–2018
▶$4MraisedNov 2018 · 33 investors · Other Health CareRule 506(b)
▶$4MraisedNov 2018 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Walter YoungDirector
- Mark LewisDirector
- Linda TuftsDirector
- Dan KidleDirector
- Nathan WoodExecutive Officer, Director
- Jack BallDirector
- Dan WatkinsDirector
- Offering amount
- $7M
- Amount sold
- $4M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.2MraisedJun 2017 · 38 investors · Other Health CareRule 506(b)
▶$12.2MraisedJun 2017 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy Harkins, PhDExecutive Officer, Director
- Peter KleinhenzDirector
- Jack Ball, Jr.Director
- Dan KidleDirector
- Dan WatkinsDirector
- Mark LewisDirector
- Walter YoungDirector
- Eric HalversonExecutive Officer
- Offering amount
- $12.2M
- Amount sold
- $12.2M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJan 2017 · 28 investors · Other Health CareRule 506(b)
▶$2.9MraisedJan 2017 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dan WatkinsDirector
- Walter YoungDirector
- Peter KleinhenzDirector
- Eric HalversonExecutive Officer
- Jack Ball, Jr.Director
- Vladimir MakarovExecutive Officer, Director
- Timothy Harkins, PhDExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $2.9M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedApr 2016 · 31 investors · Other Health CareRule 506(b)
▶$3.3MraisedApr 2016 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter KleinhenzDirector
- Dan WatkinsDirector
- Eric HalversonExecutive Officer
- Timothy Harkins, PhDExecutive Officer, Director
- Walter YoungDirector
- Jack Ball, Jr.Director
- Vladimir MakarovExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.3M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedSep 2015 · 13 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2015 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter YoungDirector
- Peter KleinhenzDirector
- Dan WatkinsDirector
- Vladimir MakarovExecutive Officer, Director
- Tim HarkinsExecutive Officer, Director
- Jack Ball, Jr.Director
- Offering amount
- $2.5M
- Amount sold
- $1.5M
- Minimum investment
- $7K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedFeb 2012 · 7 investors · BiotechnologyRule 506(b)
▶$500KraisedFeb 2012 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jack Ball, Jr.Director
- Dan WatkinsDirector
- Vladimir MakarovExecutive Officer, Director
- Walter YoungDirector
- David OlsonExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $500K
- Minimum investment
- $17.5K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Swift Biosciences do?
- Exit: Acquired by Integrated DNA Technologies, March 2021.
- Who are Swift Biosciences's investors?
- Swift Biosciences's investors include Arboretum Ventures.
- How much funding has Swift Biosciences raised?
- Swift Biosciences has disclosed $24.5M raised across 6 rounds.
- Where is Swift Biosciences headquartered?
- Swift Biosciences is headquartered in Ann Arbor, US.